Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi Looking at the year ahead in 2024, a strategy of releasing lab-modified mosquitoes to prevent the spread of dengue fever is poised to scale up after a series of successes. The Aedes aegypti mosquitoes, developed and tested by the non-profit World Mosquito Program …
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi The U.S. Food and Drug Administration (FDA) has approved a vaccine given to pregnant women to protect babies from respiratory syncytial virus (RSV). The virus causes severe lung infections that are the leading cause of U.S. infant hospitalizations. https://www.science.org/content/article/rsv-vaccine-scientific-advisory-panels-and-biodiversity-hot-spot-risk? Pregnant people …
FDA approves RSV maternal vaccine; The latest health stories from around the world Read More »
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi The UK is nearly “flying blind” when it comes to COVID this autumn, experts have said, amid an increase in cases. While the UK Health Security Agency (UKHSA) continues to track some metrics of COVID, including hospitalization numbers, many of the …
UK COVID-19 surveillance “flying blind”; The latest health stories from around the world Read More »
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi DNA-based screening methods for high-risk human papillomavirus (HPV) have proven to be highly effective for early cervical cancer detection but remain too expensive and difficult to use in resource-limited settings. Kundrod et al. have developed a prototype point-of-care test for detecting …
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi The inexpensive and widely used diabetes drug metformin decreased the risk of developing Long Covid in overweight and obese outpatients who took it while acutely ill with SARS-CoV-2 infection, researchers reported last week in The Lancet Infectious Diseases. https://www.science.org/content/article/news-glance-long-covid-treatment-global-earthquake-model-and-deep-sea-mining The risk …
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi A team of scientists says it has nailed down the major symptoms of Long Covid, which has disabled millions of people since the pandemic began. https://www.science.org/content/article/major-u-s-effort-pins-down-symptoms-long-covid? In a study published yesterday (25 May) in The Journal of the American Medical Association, …
Long COVID symptoms identified by study; The latest health stories from around the world Read More »
A new drug that can treat human African trypanosomiasis—commonly known as sleeping sickness—with just one dose has shown promise in a clinical trial in the Democratic Republic of the Congo and Guinea. www.science.org/content/article/news-at-a-glance-snags-emissions-monitoring-negotiations-biodiversity-sleeping-sickness? The rare disease is caused by the parasite Trypanosoma brucei gambiense, which is transmitted by the tsetse fly. Left untreated, it is deadly. …
Long COVID eases with time, according to a study that found about 1% of coronavirus patients had persistent symptoms for a year or more. In the first rigorous assessment of the magnitude of long COVID on a global scale, researchers found 6.2% of people who had COVID-19 in the pandemic’s first two years experienced at …
Long COVID is “devastating” the lives and livelihoods of tens of millions of people, and wreaking havoc on health systems and economies, WHO director general, Dr Tedros Adhanom Ghebreyesus has warned as he urged countries to launch “immediate” and “sustained” efforts to tackle the “very serious” crisis. www.theguardian.com/society/2022/oct/12/long-covid-who-tedros-adhanom-ghebreyesus? The world has never been in a …
Subscribe our newsletter to stay updated
Copyright © 2023 | Health Issues Africa | All rights reserved.
